Benralizumab Airway Remodeling Study in Severe Eosinophilic Asthmatics
NCT03953300
·
clinicaltrials.gov ↗
PHASE4
Phase
ACTIVE_NOT_RECRUITING
Status
75
Enrollment
INDUSTRY
Sponsor class
Conditions
Asthma
Interventions
BIOLOGICAL:
Benralizumab
BIOLOGICAL:
Placebo
Sponsor
AstraZeneca